# Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia

> **NCT07075237** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jiangsu Province Nanjing Brain Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone Palmitate Injection (PP1M)

## Key facts

- **NCT ID:** NCT07075237
- **Lead sponsor:** Jiangsu Province Nanjing Brain Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-10
- **Final completion:** 2027-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07075237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07075237, "Efficacy and Functional Recovery After Switching From Paliperidone Palmitate Injection to Oral Antipsychotics in Schizophrenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07075237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*